These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 9516014

  • 1. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
    Theodoropoulos P, Lolis D, Papageorgiou C, Papaioannou S, Plachouras N, Makrydimas G.
    Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014
    [Abstract] [Full Text] [Related]

  • 2. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA, Ibba RM, Floris M, Monni G.
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [Abstract] [Full Text] [Related]

  • 3. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
    Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH.
    Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
    [Abstract] [Full Text] [Related]

  • 4. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
    Gasiorek-Wiens A, Tercanli S, Kozlowski P, Kossakiewicz A, Minderer S, Meyberg H, Kamin G, Germer U, Bielicki M, Hackelöer BJ, Sarlay D, Kuhn P, Klapp J, Bahlmann F, Pruggmayer M, Schneider KT, Seefried W, Fritzer E, von Kaisenberg CS, German-Speaking Down Syndrome Screening Group.
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
    [Abstract] [Full Text] [Related]

  • 5. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
    Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH.
    Lancet; 1998 Aug 01; 352(9125):343-6. PubMed ID: 9717920
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
    Pandya PP, Kondylios A, Hilbert L, Snijders RJ, Nicolaides KH.
    Ultrasound Obstet Gynecol; 1995 Jan 01; 5(1):15-9. PubMed ID: 7850583
    [Abstract] [Full Text] [Related]

  • 8. Detection of sex chromosome abnormalities by nuchal translucency screening at 10-14 weeks.
    Sebire NJ, Snijders RJ, Brown R, Southall T, Nicolaides KH.
    Prenat Diagn; 1998 Jun 01; 18(6):581-4. PubMed ID: 9664603
    [Abstract] [Full Text] [Related]

  • 9. Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
    Snijders RJ, Sebire NJ, Nayar R, Souka A, Nicolaides KH.
    Am J Med Genet; 1999 Sep 17; 86(3):205-7. PubMed ID: 10482866
    [Abstract] [Full Text] [Related]

  • 10. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy.
    Nicolaides KH, Brizot ML, Snijders RJ.
    Br J Obstet Gynaecol; 1994 Sep 17; 101(9):782-6. PubMed ID: 7947527
    [Abstract] [Full Text] [Related]

  • 11. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.
    Pandya PP, Snijders RJ, Johnson SP, De Lourdes Brizot M, Nicolaides KH.
    Br J Obstet Gynaecol; 1995 Dec 17; 102(12):957-62. PubMed ID: 8652486
    [Abstract] [Full Text] [Related]

  • 12. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP, Snijders RJ, Johnson S, Nicolaides KH.
    Ultrasound Obstet Gynecol; 1995 Jun 17; 5(6):381-3. PubMed ID: 7552798
    [Abstract] [Full Text] [Related]

  • 13. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
    Pandya PP, Goldberg H, Walton B, Riddle A, Shelley S, Snijders RJ, Nicolaides KH.
    Ultrasound Obstet Gynecol; 1995 Jan 17; 5(1):20-5. PubMed ID: 7850584
    [Abstract] [Full Text] [Related]

  • 14. Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10-14 weeks of gestation.
    Hyett JA, Noble PL, Snijders RJ, Montenegro N, Nicolaides KH.
    Ultrasound Obstet Gynecol; 1996 Apr 17; 7(4):239-44. PubMed ID: 8726874
    [Abstract] [Full Text] [Related]

  • 15. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
    Sebire NJ, Snijders RJ, Hughes K, Sepulveda W, Nicolaides KH.
    Br J Obstet Gynaecol; 1996 Oct 17; 103(10):999-1003. PubMed ID: 8863698
    [Abstract] [Full Text] [Related]

  • 16. Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness.
    Noble PL, Abraha HD, Snijders RJ, Sherwood R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 1995 Dec 17; 6(6):390-5. PubMed ID: 8903913
    [Abstract] [Full Text] [Related]

  • 17. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E, van Lith JM, Mol BW, Bleker OP, Bilardo CM.
    Ultrasound Obstet Gynecol; 1998 Sep 17; 12(3):163-9. PubMed ID: 9793187
    [Abstract] [Full Text] [Related]

  • 18. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
    Zoppi MA, Ibba RM, Floris M, Manca F, Axiana C, Monni G.
    BJOG; 2003 Jun 17; 110(6):584-8. PubMed ID: 12798476
    [Abstract] [Full Text] [Related]

  • 19. First-trimester fetal nuchal translucency thickness and risk for trisomies.
    Pandya PP, Brizot ML, Kuhn P, Snijders RJ, Nicolaides KH.
    Obstet Gynecol; 1994 Sep 17; 84(3):420-3. PubMed ID: 8058241
    [Abstract] [Full Text] [Related]

  • 20. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B, Slack A, Wathen NC.
    Ultrasound Obstet Gynecol; 1997 Oct 17; 10(4):261-4. PubMed ID: 9383877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.